Back

Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study

2020-05-19 intensive care and critical care medicine Title + abstract only
View on medRxiv
Show abstract

ObjectiveTo determine if Tocilizumab treatment in patients hospitalized with laboratory confirmed SARS-CoV-2 infection and subsequent COVID-19 disease provides short-term survival benefit. DesignCase-control, observational study that includes an observation period from arrival to discharge or inpatient death. Both Cox proportional hazards and average treatment effects models were used to determine survival and treatment benefits. SettingThree Cone Health acute care hospitals including one COVI...

Predicted journal destinations

1
PLOS ONE
1737 training papers
Top 38% 17.9%
2
JAMA Network Open
125 training papers
Top 0.1% 11.1%
3
BMJ Open
553 training papers
Top 19% 7.9%
4
Frontiers in Medicine
99 training papers
Top 0.5% 6.5%
5
New England Journal of Medicine
49 training papers
Top 0.3% 6.0%
6
BMJ
49 training papers
Top 0.1% 5.1%
7
Scientific Reports
701 training papers
Top 63% 4.2%
8
Nature Communications
483 training papers
Top 36% 2.0%
9
Clinical Infectious Diseases
219 training papers
Top 14% 2.0%
10
The Journal of Infectious Diseases
137 training papers
Top 6% 2.0%
11
Critical Care Explorations
15 training papers
Top 1% 2.0%
12
BMC Medicine
155 training papers
Top 16% 1.6%
13
Clinical Microbiology and Infection
54 training papers
Top 3% 1.6%
14
The Lancet
16 training papers
#1 1.4%
15
European Respiratory Journal
44 training papers
Top 3% 1.4%
16
eLife
262 training papers
Top 34% 1.4%
17
Journal of Medical Virology
95 training papers
Top 10% 1.2%
18
Clinical Pharmacology & Therapeutics
19 training papers
Top 0.9% 1.2%
19
Infectious Diseases and Therapy
18 training papers
Top 0.4% 1.0%
20
Trials
24 training papers
Top 2% 1.0%
21
Vaccine
140 training papers
Top 10% 0.7%
22
Frontiers in Immunology
140 training papers
Top 13% 0.7%
23
Open Forum Infectious Diseases
124 training papers
Top 16% 0.7%
24
PLOS Medicine
95 training papers
Top 23% 0.7%
25
The Lancet Respiratory Medicine
16 training papers
Top 0.8% 0.5%